A study by scientists at Sanford Burnham Prebys Medical Discovery Institute suggests that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check and could provide a new path toward future treatments for Alzheimer’s disease. Read more.
Protein identified as critical for keeping Alzheimer’s disease pathology in check
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.